Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Baker Hughes CoBKR · Entity 2993 | Director | May 19, 2026 | May 21, 2026 |
| STERIS plcSTE · Entity 3228 | Director | August 10, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Baker Hughes Co
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock Unit 05_26SEC Table II · derivative / convertible security | Direct | 2,749 |
Reported balance
After 2026-05-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 2,749 · Balance 2,749 F1: Each Deferred Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2: The Deferred Stock Units vested immediately on the date of grant and will settle within 30 days after retirement. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer.
F2: The Deferred Stock Units vested immediately on the date of grant and will settle within 30 days after retirement.
STERIS plc
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 24,305 |
Ending reported balance
After 2026-08-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-12 · Exercise / conversion · Acquired 4,058 · Balance 28,363 Row 2 · 2026-08-12 · Sale · Disposed 4,058 · Balance 24,305 F1: Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $238.91 · Expires 2036-08-10 | Direct | 1,099 |
Reported balance
After 2026-08-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-10 · Grant · Acquired 1,099 · Balance 1,099 F2: These nonqualified stock options are fully vested and are exercisable immediately. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09 | Direct | 0 |
Reported balance
After 2026-08-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-12 · Exercise / conversion · Disposed 4,058 · Balance 0 F5: This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,979 |
Reported balance
After 2026-08-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-08-10 · Grant · Acquired 1,229 · Balance 8,979 F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. |
Filing footnotes · ownership attribution and instrument terms
F1: Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: These nonqualified stock options are fully vested and are exercisable immediately.
F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
F5: This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 22,361 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.34 · Expires 2020-08-04 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 3,133 · Balance 0 F2: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.61 · Expires 2021-08-03 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 3,121 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.36 · Expires 2022-08-03 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 3,218 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.92 · Expires 2023-08-08 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 2,069 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,069 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.53 · Expires 2024-08-06 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 2,037 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,037 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.05 · Expires 2025-08-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 4,110 · Balance 0 F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.40 · Expires 2026-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-03-28 · Disposition to issuer · Disposed 3,781 · Balance 0 F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-03-28 · Disposition to issuer · Disposed 4,058 · Balance 0 F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.74 · Expires 2028-08-09 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-03-28 · Disposition to issuer · Disposed 4,893 · Balance 0 F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,893 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2019-03-28 · Disposition to issuer · Disposed 688 · Balance 0 F11: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 688 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F2: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,069 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 2,037 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,058 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,893 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F11: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 688 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2026 Filed Aug 12, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 4,058 | $0.00 Strike: $86.23 | $0.00 |
DisclosureSEC source: 0001628280-26-056270 · wk-form4_1786566834.xml · derivative · entry 5 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| August 12, 2026 Filed Aug 12, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 4,058 | $235.78 | $956,795.24 |
DisclosureSEC source: 0001628280-26-056270 · wk-form4_1786566834.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,305 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2026 Filed Aug 12, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 4,058 | $86.23 | $349,921.34 |
DisclosureSEC source: 0001628280-26-056270 · wk-form4_1786566834.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 1,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-056270 · wk-form4_1786566834.xml · derivative · entry 4 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,979 Underlying: Ordinary Shares · 1,229 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:33 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 1,099 | $0.00 Strike: $238.91 | $0.00 |
DisclosureSEC source: 0001628280-26-056270 · wk-form4_1786566834.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,099 Underlying: Ordinary Shares · 1,099 shares Expires 2036-08-10 F2 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 3,781 | $0.00 Strike: $71.40 | $0.00 |
DisclosureSEC source: 0001628280-26-046946 · wk-form4_1783024268.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,781 ordinary shares for $71.40 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:31 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 1,837 | $212.30 | $389,995.10 |
DisclosureSEC source: 0001628280-26-046946 · wk-form4_1783024268.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,305 F1 · shares: Net - Cashless Stock Option Exercise - Options to purchase 1,837 shares were surrendered to the Company for payment of the option price. Options surrendered were valued based on the Company stock closing market price on the NYSE on the day on which the Net - Cashless Stock Option Exercise occurred. F1 · price: Net - Cashless Stock Option Exercise - Options to purchase 1,837 shares were surrendered to the Company for payment of the option price. Options surrendered were valued based on the Company stock closing market price on the NYSE on the day on which the Net - Cashless Stock Option Exercise occurred. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:31 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 3,781 | $71.40 | $269,963.40 |
DisclosureSEC source: 0001628280-26-046946 · wk-form4_1783024268.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,142 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:51 UTC | Baker Hughes Co BKR · Entity 2993 | GrantDeferred Stock Unit 05_26 · Derivative | 2,749 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001293588-26-000002 · wk-form4_1779396696.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,749 Underlying: Class A Common Stock · 2,749 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each Deferred Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: The Deferred Stock Units vested immediately on the date of grant and will settle within 30 days after retirement. F2 · derivative.expiration_date: The Deferred Stock Units vested immediately on the date of grant and will settle within 30 days after retirement. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:22 UTC | Baker Hughes Co BKR · Entity 2993 | Exercise / conversionDeferred Stock Unit · Derivative | 3,932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001293588-25-000004 · wk-form4_1766006544.xml · derivative · entry 5 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F5 · derivative.exercise_date: The reported transaction represents the receipt of shares in settlement of fully vested Deferred Stock Units granted on December 15, 2023 in respect of 2023 retainer fees that the reporting person previously elected to receive in stock with settlement deferred, pursuant to the Issuer's Non-Employee Director Deferral Plan, until December 15, 2025. F5 · derivative.expiration_date: The reported transaction represents the receipt of shares in settlement of fully vested Deferred Stock Units granted on December 15, 2023 in respect of 2023 retainer fees that the reporting person previously elected to receive in stock with settlement deferred, pursuant to the Issuer's Non-Employee Director Deferral Plan, until December 15, 2025. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:22 UTC | Baker Hughes Co BKR · Entity 2993 | Exercise / conversionRestricted Stock Unit · Derivative | 6,377 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001293588-25-000004 · wk-form4_1766006544.xml · derivative · entry 4 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,377 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F4 · derivative.exercise_date: The reported transaction represents the receipt of shares in settlement of fully vested Restricted Stock Units granted on May 16, 2023, for which the reporting person previously elected, pursuant to the Issuer's Non-Employee Director Deferral Plan, to defer settlement until December 15, 2025. F4 · derivative.expiration_date: The reported transaction represents the receipt of shares in settlement of fully vested Restricted Stock Units granted on May 16, 2023, for which the reporting person previously elected, pursuant to the Issuer's Non-Employee Director Deferral Plan, to defer settlement until December 15, 2025. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:22 UTC | Baker Hughes Co BKR · Entity 2993 | GrantDeferred Stock Units 12_25 · Derivative | 3,447.994 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001293588-25-000004 · wk-form4_1766006544.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,447.994 Underlying: Class A Common Stock · 3,447.994 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2 · shares: The amount reported in Column 5 includes 26.655 Deferred Stock Units received as dividend equivalents. F1 · price: Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F3 · derivative.exercise_date: The Deferred Stock Units were fully vested on the date of grant, December 15, 2025. Pursuant to the Issuer's Non-Employee Director Deferral Plan, the reporting person elected to receive their 2025 retainer fees in stock and to defer delivery of the shares until the date the reporting person ceases to serve as a director. F3 · derivative.expiration_date: The Deferred Stock Units were fully vested on the date of grant, December 15, 2025. Pursuant to the Issuer's Non-Employee Director Deferral Plan, the reporting person elected to receive their 2025 retainer fees in stock and to defer delivery of the shares until the date the reporting person ceases to serve as a director. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:22 UTC | Baker Hughes Co BKR · Entity 2993 | Exercise / conversionClass A Common Stock | 3,932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001293588-25-000004 · wk-form4_1766006544.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:22 UTC | Baker Hughes Co BKR · Entity 2993 | Exercise / conversionClass A Common Stock | 6,377 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001293588-25-000004 · wk-form4_1766006544.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit and each Restricted Stock Unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 21:28 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 4,110 | $0.00 Strike: $64.05 | $0.00 |
DisclosureSEC source: 0001628280-25-039974 · wk-form4_1755034076.xml · derivative · entry 6 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option to purchase 4,110 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,110 ordinary shares for $64.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 21:28 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 4,110 | $241.96 | $994,455.60 |
DisclosureSEC source: 0001628280-25-039974 · wk-form4_1755034076.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,361 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $241.36 to $242.295 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 21:28 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 4,110 | $64.05 | $263,245.50 |
DisclosureSEC source: 0001628280-25-039974 · wk-form4_1755034076.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:28 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 506 | $242.85 | $122,882.10 |
DisclosureSEC source: 0001628280-25-039974 · wk-form4_1755034076.xml · derivative · entry 5 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,750 Underlying: Ordinary Shares · 506 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $123,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:28 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 772 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039974 · wk-form4_1755034076.xml · derivative · entry 4 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,244 Underlying: Ordinary Shares · 772 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:28 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 2,226 | $0.00 Strike: $242.85 | $0.00 |
DisclosureSEC source: 0001628280-25-039974 · wk-form4_1755034076.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,226 Underlying: Ordinary Shares · 2,226 shares Expires 2035-08-08 F2 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| May 20, 2025 Filed May 22, 2025 22:13 UTC | Baker Hughes Co BKR · Entity 2993 | GrantDeferred Stock Unit 05_25 · Derivative | 4,820 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701605-25-000093 · wk-form4_1747951990.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,820 Underlying: Class A Common Stock · 4,820 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each deferred stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: The deferred stock units vested immediately on the date of grant and will settle within 30 days after retirement. F2 · derivative.expiration_date: The deferred stock units vested immediately on the date of grant and will settle within 30 days after retirement. Read SEC document |
| December 16, 2024 Filed Dec 19, 2024 02:02 UTC | Baker Hughes Co BKR · Entity 2993 | GrantDeferred Stock Units 12_24 · Derivative | 3,971 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701605-24-000143 · wk-form4_1734573716.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,971 Underlying: Class A Common Stock · 3,971 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Class A common Stock of the Issuer. F1 · price: Each Deferred Stock Unit represents a right to receive one share of Class A common Stock of the Issuer. F2 · derivative.exercise_date: The Deferred Stock Units vested immediately on the date of grant, December 16, 2024. Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to receive their 2024 retainer fees in stock and to defer delivery of the shares until the earlier of December 15, 2026, and the date the reporting person ceases to serve as a director. F2 · derivative.expiration_date: The Deferred Stock Units vested immediately on the date of grant, December 16, 2024. Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to receive their 2024 retainer fees in stock and to defer delivery of the shares until the earlier of December 15, 2026, and the date the reporting person ceases to serve as a director. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:38 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 95 | $239.68 | $22,769.60 |
DisclosureSEC source: 0001628280-24-036801 · wk-form4_1723495093.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,151 Underlying: Ordinary Shares · 95 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $23,000. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:38 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036801 · wk-form4_1723495093.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,056 Underlying: Ordinary Shares · 783 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:38 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 2,197 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036801 · wk-form4_1723495093.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,197 Underlying: Ordinary Shares · 2,197 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Oct 2, 2024 20:31 UTC Amendment | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 417 | $239.68 | $99,946.56 |
DisclosureSEC source: 0001628280-24-041916 · wk-form4a_1727901066.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,472 Underlying: Ordinary Shares · 417 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · shares: This Form 4 Amendment is being filed to correct the amount of Career Restricted Stock Units previously reported. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $100,000. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · balance_after: This Form 4 Amendment is being filed to correct the amount of Career Restricted Stock Units previously reported. Read SEC document |
| August 08, 2024 Filed Oct 2, 2024 20:31 UTC Amendment | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-041916 · wk-form4a_1727901066.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,055 Underlying: Ordinary Shares · 782 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · shares: This Form 4 Amendment is being filed to correct the amount of Career Restricted Stock Units previously reported. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · balance_after: This Form 4 Amendment is being filed to correct the amount of Career Restricted Stock Units previously reported. Read SEC document |
| May 22, 2024 Filed May 24, 2024 22:58 UTC | Baker Hughes Co BKR · Entity 2993 | GrantRestricted Stock Unit D 05_24 · Derivative | 5,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701605-24-000096 · wk-form4_1716591497.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,453 Underlying: Class A Common Stock · 5,453 shares Expires 2024-05-22 F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: The restricted stock units vested immediately on the date of grant. Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to defer delivery of the shares until December 15, 2026 and received the equivalent number of deferred stock units. F2 · derivative.expiration_date: The restricted stock units vested immediately on the date of grant. Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to defer delivery of the shares until December 15, 2026 and received the equivalent number of deferred stock units. F2 · balance_after: The restricted stock units vested immediately on the date of grant. Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to defer delivery of the shares until December 15, 2026 and received the equivalent number of deferred stock units. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 2,037 | $0.00 Strike: $51.53 | $0.00 |
DisclosureSEC source: 0001628280-24-023800 · wk-form4_1715891577.xml · derivative · entry 4 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,037 shares Expires 2024-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 2,037 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 2,037 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 1,438 | $234.04 | $336,549.52 |
DisclosureSEC source: 0001628280-24-023800 · wk-form4_1715891577.xml · nonDerivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,361 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $233.47 to $234.3750 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 599 | $232.96 | $139,543.04 |
DisclosureSEC source: 0001628280-24-023800 · wk-form4_1715891577.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,799 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $232.46 to $233.45 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 2,037 | $51.53 | $104,966.61 |
DisclosureSEC source: 0001628280-24-023800 · wk-form4_1715891577.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 21:22 UTC | Baker Hughes Co BKR · Entity 2993 | GrantDeferred Stock Unit · Derivative | 3,932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701605-23-000095 · wk-form4_1703020942.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,932 Underlying: Class A Common Stock · 3,932 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Class A Common Stock of the Issuer. F1 · price: Each Deferred Stock Unit represents a right to receive one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to receive their 2023 retainer fees in stock and defer delivery of the shares until December 15, 2025. F2 · derivative.expiration_date: Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to receive their 2023 retainer fees in stock and defer delivery of the shares until December 15, 2025. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 279 | $225.50 | $62,914.50 |
DisclosureSEC source: 0001209191-23-044825 · doc4.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,273 Underlying: Ordinary Shares · 279 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $63,000 in fees. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 831 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044825 · doc4.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,994 Underlying: Ordinary Shares · 831 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 2,443 | $0.00 Strike: $225.50 | $0.00 |
DisclosureSEC source: 0001209191-23-044825 · doc4.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,443 Underlying: Ordinary Shares · 2,443 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:31 UTC | Baker Hughes Co BKR · Entity 2993 | GrantRestricted Stock Unit · Derivative | 6,377 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018886 · wk-form4_1684441878.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,377 Underlying: Class A Common Stock · 6,377 shares Expires 2023-05-16 F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: This is a grant of restricted stock units that vests immediately on the date of grant. Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to defer delivery of the shares until December 15, 2025 and received the equivalent number of deferred stock units. F2 · derivative.expiration_date: This is a grant of restricted stock units that vests immediately on the date of grant. Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to defer delivery of the shares until December 15, 2025 and received the equivalent number of deferred stock units. F2 · balance_after: This is a grant of restricted stock units that vests immediately on the date of grant. Pursuant to the Issuer's Director Deferral Plan, the reporting person elected to defer delivery of the shares until December 15, 2025 and received the equivalent number of deferred stock units. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 2,069 | $0.00 Strike: $43.92 | $0.00 |
DisclosureSEC source: 0001209191-23-029816 · doc4.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,069 shares Expires 2023-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option to purchase 2,069 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 2,069 Old STERIS ordinary shares for $43.92 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 2,069 | $212.28 | $439,207.32 |
DisclosureSEC source: 0001209191-23-029816 · doc4.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,361 Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 2,069 | $43.92 | $90,870.48 |
DisclosureSEC source: 0001209191-23-029816 · doc4.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:54 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 842 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044586 · doc4.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,163 Underlying: Ordinary Shares · 842 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:54 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 2,743 | $0.00 Strike: $203.00 | $0.00 |
DisclosureSEC source: 0001209191-22-044586 · doc4.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,743 Underlying: Ordinary Shares · 2,743 shares Expires 2032-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:39 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 751 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051124 · doc4.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,321 Underlying: Ordinary Shares · 751 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:39 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 3,081 | $0.00 Strike: $217.62 | $0.00 |
DisclosureSEC source: 0001209191-21-051124 · doc4.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,081 Underlying: Ordinary Shares · 3,081 shares Expires 2031-08-10 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:37 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045481 · doc4.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,570 Underlying: Ordinary Shares · 924 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:37 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 4,360 | $0.00 Strike: $158.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045481 · doc4.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,360 Underlying: Ordinary Shares · 4,360 shares Expires 2030-08-04 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 20:35 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,218 | $0.00 Strike: $32.36 | $0.00 |
DisclosureSEC source: 0001209191-20-033204 · doc4.xml · derivative · entry 4 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 20:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Shares | 550 | $164.68 | $90,574.00 |
DisclosureSEC source: 0001209191-20-033204 · doc4.xml · nonDerivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,361 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $164.58 to $164.74 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 20:35 UTC | STERIS plc STE · Entity 3228 | SaleOrdinary Share | 2,668 | $164.00 | $437,552.00 |
DisclosureSEC source: 0001209191-20-033204 · doc4.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,911 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $163.50 to $164.50 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 20:35 UTC | STERIS plc STE · Entity 3228 | Exercise / conversionOrdinary Shares | 3,218 | $32.36 | $104,134.48 |
DisclosureSEC source: 0001209191-20-033204 · doc4.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.